Treatment Registry
TR-0400 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by OurView · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$129

Medication · Month-to-Month$129

Added from the figures recorded below.

Price

TermPer monthCharged today
Month-to-Month

Month-to-Month $129 per month

source

Per month$129Charged today$129
3 Months in Full

3 Months in Full $119 per month Save $10— $357 today

source

Per month$119Charged today$357
Visit OurView

We earn nothing from this link. OurView has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyOurView's own parent company, an unnamed licensed nationwide pharmacy
StatesAll states except Arkansas, Connecticut, Hawaii, and New Jersey (plus the District of Columbia)
PrescriberBoth
Cancellation“You can always login to your https://www.ourviewhealth.com account before your products ship to change your address, method of payment or to cancel your subscription.”

Not yet checked: membership and consult fee.

Recorded from ourviewhealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The homepage advertises flat pricing of '$99/month Semaglutide' and '$119/month Tirzepatide' with 'No membership fee', but the actual order pages (personalized-glp-1/, personalized-glp-1-gip/) price the month-to-month plan at $109 and $129 respectively — $99/$119 is only reached by paying 3 months upfront ($297/$357 today). Separately, the homepage's 'membership' comparison table shows a third, lower price ('GLP-1 Medication $75' with membership vs '$90' without) that matches neither the $99/$119 headline nor the $109/$129 month-to-month order price, and no page states what the membership itself costs per month. No page checked states whether the medication ships as a vial or a pen, so form is recorded as not-disclosed.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0400
Readings
1

Related records

What else OurView sells

All OurView programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). OurView compounded tirzepatide (TR-0400). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0400

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.